cml Resources | BNET
On GameSpot: Wii Fit tells 10-year-old she's fat

Resources

137 Resources for

cml

  • Subscribe to this listing via:
  • RSS
  • Email
Vaccine for Chronic Myeloid Leukemia Highlighted in Lancet Publication; Vaccine Significantly Improves Molecular Remission Rate of Patients with Persistent CML
GREENWICH, Conn. -- Breakthrough Therapeutics, a privately owned biotechnology company, today announced the publication of positive data with a vaccine for chronic myeloid leukemia CML known as VAX100, in the Journal Lancet. VAX100 is a BCR-ABL peptide vaccine designed to reduce persistent disease in patients with CML whom have had...
Tags: Molecular Inc., patient, vaccine
Research articles 2005-03-01
Discovery Communications Inc. Finalizes Acquisition of The Nature Company
BETHESDA, Md.--BUSINESS WIRE--June 6, 1996--Privately held Discovery Communications, Inc. DCI, parent company of cable television's Discovery Channel, today confirmed the closing of its purchase of the assets of The Nature Company from CML Group, Inc. (NYSE: CML) for $40 million.
Tags: acquisition, Discovery Communications Inc.
Research articles 1996-06-06
Massachusetts' CML Group Inc. to Sell Nature Company Retail Chain.(Originated from The Boston Globe)
Apr. 30--Looking to focus on its core exercise and gardening businesses, CML Group Inc. of Acton said yesterday that it has agreed to sell its 117- store The Nature Company chain to Discovery Communications Inc., owner of the Discovery Channel, for $40Apr. 30--Looking to focus on its...
Tags: Boston Globe
Research articles 1996-04-30
New Study by ARIAD Scientists Offers Insights into Design of Small-Molecule Drugs to Treat Drug-Resistant Leukemia
CAMBRIDGE, Mass. -- ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced publication, for the first time, of the high-resolution structure of the protein responsible for one of the major clinically relevant genetic variants of drug-resistant chronic myeloid leukemia CML. These findings by a team of ARIAD scientists were used to guide...
Research articles 2007-10-09
Gleevec approved for first-line CML treatment
The Food and Drug Administration FDA announced in late December the approval of Gleevec (imatinib mesylate; Novartis Pharmaceuticals Corporation) for the first-line treatment of patients with chronic myeloid leukemia CML. Gleevec was first approved inThe Food and Drug Administration FDA announced in late December the approval of Gleevec (imatinib mesylate;...
Tags: FDA
Research articles 2003-03-01
NEC Corporation Announces Extended Reach XFP Transceiver Based on AZNA CML TOSA
Tokyo, Japan, Mar 27, 2007 - JCN Newswire - NEC has demonstrated an extended reach 10 Gbps XFP transceiver for 160 km links without dispersion compensation. This transceiver leverages NEC's Planar Lightwave Circuit PLC technologies with AZNA's extended reach Chirp Managed Laser CML technology for a potentially low cost,...
Tags: NEC Corp.
Research articles 2007-03-27
NEC Corporation Announces Extended Reach XFP Transceiver Based on AZNA CML TOSA
NEC has demonstrated an extended reach 10 Gbps XFP transceiver for 160 km links without dispersion compensation. This transceiver leverages NEC's Planar Lightwave Circuit PLC technologies with AZNA's extended reach Chirp Managed Laser CML technology for a potentially low...
Tags: NEC Corp.
Research articles 2007-03-27
Vaccine for Chronic Myeloid Leukemia Active in Patients with Persistent Disease; Vaccine Demonstrated Improved Molecular Remission Rate of Patients with Persistent CML After Imatinib; US Multi-center Trial Opened
GREENWICH, Conn. -- Breakthrough Therapeutics, a privately owned biotechnology company, today announced the presentation of positive interim data for a novel vaccine known as VAX100 for patients with persistent chronic myeloid leukemia CML while on imatinib mesylate (GleevecR; Novartis). This two-year follow-up data was presented at the annual American Society...
Tags: Molecular Inc., patient, vaccine
Research articles 2006-01-05
AUSTRALIA'S COLES MYER POSTS US$129.54 MLN H1 NET PROFIT.
MELBOURNE, March 17 Asia Pulse - Tabulated results for Coles Myer Ltd (ASX:CML), 26 weeks to January 26, 2003. MELBOURNE, March 17 Asia Pulse - Tabulated results for Coles Myer Ltd (ASX:CML), 26 weeks to January 26, 2003.
Research articles 2003-03-17
Finisar Delivers World's First Narrowly Tunable Long-Reach CML(TM) Butterfly Transmitters for Metro, Regional, and Long-Haul DWDM Optical Networks
Continuing to lead the drive for innovation in the high-end telecom market, Finisar Corporation (NASDAQ: FNSR) today announced the completion of Telcordia GR-468 qualification and general availability of its 10 Gbps DM80 and DM200 narrowly tunable CMLTM Butterfly Transmitters for DWDM 300-pin transponders and telecom line card applications. Leveraging...
Tags: transmitter
Research articles 2007-08-22
GlobeImmune, Inc. Announces Presentation of Pre-Clinical Data on GI-10001 for Chronic Myelogenous Leukemia (CML) at International Conference on Molecular Targets and Cancer Therapeutics
GlobeImmune, Inc. announced today results from research on its GI-10001 Tarmogen® which is being investigated for the treatment of drug resistant chronic myelogenous leukemia CML. Leukemia driven by the Bcr-Abl T315I mutation, known as the "gate-keeper" mutation, is resistant to treatment with imatinib mesylate or newer tyrosine kinase inhibitors including...
Tags: Molecular Inc.
Research articles 2007-10-25
Maker of NordicTrack Reports Sales Decline, Quarterly Losses.(Originated from The Boston Globe)
Oct. 1--The CML Group of Acton, perhaps best known for its NordicTrack exercise equipment, yesterday reported sales drops and losses for its fourth quarter and fiscal 1996. Oct. 1--The CML Group of Acton, perhaps best known for its NordicTrack exercise equipment, yesterday reported sales drops and...
Tags: Boston Globe, quarterly loss, sales
Research articles 1996-10-01
Spectrum Signal Processing Announces CML Versatel as a Customer for aXs Voice over Packet Solutions
Business Editors
Research articles 2001-08-16
Finisar Demonstrates Interoperability of Chirp Managed Laser (CML(TM)) and Optical Duobinary (ODB) Technologies Over 200 km at 10 Gbps Without Dispersion Compensation at ECOC 2007
Showcasing key technologies that it recently acquired, Finisar Corporation (NASDAQ: FNSR) today announced an interoperability demonstration between its Chirp Managed Laser (CMLTM) and Optical Duobinary ODB technologies, transmitting 10 Gbps traffic over 200 km of single mode fiber. Finisar is the first company to offer its customers these two...
Tags: compensation, laser, technology
Research articles 2007-09-17
2 PCT FALL IN SHARE PRICE FOR AUSTRALIA'S COLES MYER TODAY.
MELBOURNE, Feb 11 Asia Pulse - Coles Myer Ltd (ASX:CML) shares were back on the slippery slide today, falling more than two per cent. MELBOURNE, Feb 11 Asia Pulse - Coles Myer Ltd (ASX:CML) shares were back on the slippery slide today, falling more...
Research articles 2003-02-11
PLANS OF AUSTRALIA'S COLES MYER TO DOUBLE PROFITS ACHIEVABLE: ANALYSTS.
BRISBANE, April 1 Asia Pulse - The top boss at Coles Myer Ltd (ASX:CML) who has drawn up a blueprint to turn around the ailing retail giant within five years, admits it will be "no walk in the park". BRISBANE, April 1 Asia Pulse...
Research articles 2002-04-01
Courage Under Fire
Gleevec’s discovery, development, and launch was a momentous experience that broke records at every stage: scientists delivering dramatic product efficacy never seen before in the history of cancer treatment; Novartis teams pulling together to greatly accelerate clinical trials, and rapid regulatory approvals. It seemed a perfect story. Indeed, to an...
Tags: Management, Team Management, Healthcare, Gleevec, Leadership
White papers 2003-04-01
RETAILER COLES MYER REPORTEDLY EYEING BANKING SERVICE.
SYDNEY, May 24 Asia Pulse - Coles Myer Ltd (ASX:CML) Australia's biggest retailer, is believed to be close to offering in-store banking facilities. SYDNEY, May 24 Asia Pulse - Coles Myer Ltd (ASX:CML) Australia's biggest retailer, is believed to be close to offering in-store...
Tags: retail company
Research articles 2002-05-24
SHARES IN AUSTRALIA'S COLES MYER EASE ON MODEST GROWTH OUTLOOK.
SYDNEY, Nov 14 Asia Pulse - Coles Myer Ltd (ASX:CML) shares fell again today as analysts pointed to earnings risks in the grocery sector because of increased competition. SYDNEY, Nov 14 Asia Pulse - Coles Myer Ltd (ASX:CML) shares fell again today as analysts...
Research articles 2003-11-14
AUSTRALIA'S COLES MYER CEO OUTLINES COMPANY PROFILE.
MELBOURNE, Oct 3 Asia Pulse - Coles Myer Ltd (ASX:CML) chief executive John Fletcher admits he's still not a retail expert after 12 months in the job but at least he's become a regular supermarket visitor. MELBOURNE, Oct 3 Asia Pulse - Coles Myer Ltd...
Research articles 2002-10-03
advertisement
advertisement